1. Home
  2. INZY vs HITI Comparison

INZY vs HITI Comparison

Compare INZY & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • HITI
  • Stock Information
  • Founded
  • INZY 2015
  • HITI 2009
  • Country
  • INZY United States
  • HITI Canada
  • Employees
  • INZY N/A
  • HITI N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • HITI
  • Sector
  • INZY Health Care
  • HITI
  • Exchange
  • INZY Nasdaq
  • HITI Nasdaq
  • Market Cap
  • INZY 256.3M
  • HITI 187.8M
  • IPO Year
  • INZY 2020
  • HITI N/A
  • Fundamental
  • Price
  • INZY $4.00
  • HITI $2.36
  • Analyst Decision
  • INZY Buy
  • HITI Strong Buy
  • Analyst Count
  • INZY 9
  • HITI 2
  • Target Price
  • INZY $15.22
  • HITI $4.75
  • AVG Volume (30 Days)
  • INZY 989.2K
  • HITI 282.2K
  • Earning Date
  • INZY 08-05-2025
  • HITI 06-16-2025
  • Dividend Yield
  • INZY N/A
  • HITI N/A
  • EPS Growth
  • INZY N/A
  • HITI N/A
  • EPS
  • INZY N/A
  • HITI N/A
  • Revenue
  • INZY N/A
  • HITI $398,202,371.00
  • Revenue This Year
  • INZY N/A
  • HITI $12.43
  • Revenue Next Year
  • INZY N/A
  • HITI $11.39
  • P/E Ratio
  • INZY N/A
  • HITI N/A
  • Revenue Growth
  • INZY N/A
  • HITI 9.22
  • 52 Week Low
  • INZY $0.72
  • HITI $1.57
  • 52 Week High
  • INZY $6.24
  • HITI $3.62
  • Technical
  • Relative Strength Index (RSI)
  • INZY 82.66
  • HITI 55.44
  • Support Level
  • INZY $3.94
  • HITI $2.24
  • Resistance Level
  • INZY $3.97
  • HITI $2.35
  • Average True Range (ATR)
  • INZY 0.01
  • HITI 0.09
  • MACD
  • INZY -0.08
  • HITI 0.01
  • Stochastic Oscillator
  • INZY 100.00
  • HITI 92.00

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: